Felbamate

• CAT Number: A000408
• CAS Number: 25451-15-4
• Molecular Formula: C11H14N2O4
• Molecular Weight: 238.2
• Purity: ≥95%
• Synonyms: 25451-15-4; Felbatol; 2-Phenylpropane-1,3-diyl dicarbamate; 2-Phenyl-1,3-propanediol dicarbamate; Felbamyl
• Target: Neuronal Signaling
• Solubility: Soluble in DMSO > 10 mM
• Storage: -20°C
• InChI: 1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)
• InChIKey: WKGXYQFOCVYPAC-UHFFFAOYSA-N
• SMILES: C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N

Felbamate is an anti-epileptic drug used in the treatment of epilepsy. Felbamate has been proposed to a unique dual mechanism of action as a positive modulator of GABAA receptors and as a blocker of NMDA receptors, particularly isoforms containing the NR2B subunit. Although it is clear that felbamate does cause pharmacological inhibition of NMDA receptors, the relevance of NMDA receptor blockade as a strategy for the treatment of human epilepsy has been questioned. Therefore, the importance of the effects of felbamate on NMDA receptors to its therapeutic action in epilepsy is uncertain.

Reference

1: Shi LL, Dong J, Ni H, Geng J, Wu T. Felbamate as an add-on therapy for
refractory partial epilepsy. Cochrane Database Syst Rev. 2017 Jul 18;7:CD008295.
doi: 10.1002/14651858.CD008295.pub4. Review. PubMed PMID: 28718506.

2: Shah YD, Singh K, Friedman D, Devinsky O, Kothare SV. Evaluating the safety
and efficacy of felbamate in the context of a black box warning: A single center
experience. Epilepsy Behav. 2016 Mar;56:50-3. doi: 10.1016/j.yebeh.2016.01.006.
Epub 2016 Jan 30. PubMed PMID: 26828692.

3: Mishal NM, Arkilo D, Tang J, Crawford JR, Wang SG. A Potential Role for
Felbamate in TSC- and NF1-Related Epilepsy: A Case Report and Review of the
Literature. Case Rep Neurol Med. 2015;2015:960746. doi: 10.1155/2015/960746. Epub
2015 Oct 22. PubMed PMID: 26579319; PubMed Central PMCID: PMC4633543.

4: Thakkar K, Billa G, Rane J, Chudasama H, Goswami S, Shah R. The rise and fall
of felbamate as a treatment for partial epilepsy–aplastic anemia and hepatic
failure to blame? Expert Rev Neurother. 2015;15(12):1373-5. doi:
10.1586/14737175.2015.1113874. Epub 2015 Nov 13. PubMed PMID: 26566191.

5: Coorg R, Weisenberg JL. Successful Treatment of Electrographic Status
Epilepticus of Sleep With Felbamate in a Patient With SLC9A6 Mutation. Pediatr
Neurol. 2015 Dec;53(6):527-31. doi: 10.1016/j.pediatrneurol.2015.07.007. Epub
2015 Jul 22. PubMed PMID: 26421989.

6: Shi LL, Dong J, Ni H, Geng J, Wu T. Felbamate as an add-on therapy for
refractory epilepsy. Cochrane Database Syst Rev. 2014 Jul 18;(7):CD008295. doi:
10.1002/14651858.CD008295.pub3. Review. Update in: Cochrane Database Syst Rev.
2017 Jul 18;7:CD008295. PubMed PMID: 25036694.

7: Heyman E, Levin N, Lahat E, Epstein O, Gandelman-Marton R. Efficacy and safety
of felbamate in children with refractory epilepsy. Eur J Paediatr Neurol. 2014
Nov;18(6):658-62. doi: 10.1016/j.ejpn.2014.05.005. Epub 2014 May 22. PubMed PMID:
24906615.

8: Ghousheh AI, Groth TW, Fryjoff KM, Wille DF, Mandel NS, Roddy JT, Durkee CT.
Urolithiasis in patients on high dose felbamate. J Urol. 2013 May;189(5):1865-9.
doi: 10.1016/j.juro.2012.12.032. Epub 2012 Dec 21. PubMed PMID: 23262038.

9: Shi LL, Dong J, Ni H, Geng J, Wu T. Felbamate as an add-on therapy for
refractory epilepsy. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008295. doi:
10.1002/14651858.CD008295.pub2. Review. Update in: Cochrane Database Syst Rev.
2014;7:CD008295. PubMed PMID: 21249704.

10: Hansen RJ, Samber BJ, Gustafson DL. Rapid and sensitive LC-MS/MS method for
determination of felbamate in mouse plasma and tissues and human plasma. J
Chromatogr B Analyt Technol Biomed Life Sci. 2010 Dec 15;878(32):3432-6. doi:
10.1016/j.jchromb.2010.10.006. Epub 2010 Oct 16. PubMed PMID: 21081288; PubMed
Central PMCID: PMC4278804.